首页 >>> 产品目录 >>> 化合物对照品/标准品 >>> 癌症(肿瘤)研究系列
仪表展览网 >>> 展馆展区 >>> 标准物质/溶液 >>> 标准样品 >>> 现货供应对照品Dovitinib lactate(TKI258)/多韦替尼乳酸盐
> 现货供应对照品Dovitinib lactate(TKI258)/多韦替尼乳酸盐

产品资料

现货供应对照品Dovitinib lactate(TKI258)/多韦替尼乳酸盐

现货供应对照品Dovitinib lactate(TKI258)/多韦替尼乳酸盐
  • 如果您对该产品感兴趣的话,可以
  • 产品名称:现货供应对照品Dovitinib lactate(TKI258)/多韦替尼乳酸盐
  • 产品型号:C13587
  • 产品展商:Chembest
  • 产品文档:无相关文档
简单介绍
Chemical Name: 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate hydrate (1:1:1) 别名:CHIR-258 英文名:Dovitinib lactate 分子式:C21H21FN6O.C3H6O3.H2O 分子
产品描述
Chemical Name: 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate hydrate (1:1:1)
别名:CHIR-258
英文名:Dovitinib lactate
分子式:C21H21FN6O.C3H6O3.H2O
分子量:500.53
外观:Brown crystal powder
纯度:>99%
CAS:915769-50-5
Biological Activity:
Dovitinib lactate is the orally bioavailable lactate salt of a benzimidazole-quinolinone compound with potential antineoplastic activity. Dovitinib strongly binds to fibroblast growth factor receptor 3 (FGFR3) and inhibits its phosphorylation, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell death. In addition, this agent may inhibit other members of the RTK superfamily, including the vascular endothelial growth factor receptor; fibroblast growth factor receptor 1; platelet-derived growth factor receptor type 3; FMS-like tyrosine kinase 3; stem cell factor receptor (c-KIT); and colony-stimulating factor receptor 1; this may result in an additional reduction in cellular proliferation and angiogenesis, and the induction of tumor cell apoptosis. The activation of FGFR3 is associated with cell proliferation and survival in certain cancer cell types.
产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
  • 温馨提示:为规避购买风险,建议您在购买前务必确认供应商资质与产品质量。
  • 免责申明:以上内容为注册会员自行发布,若信息的真实性、合法性存在争议,平台将会监督协助处理,欢迎举报
产品留言
标题
内容
联系人
联系电话
电子邮件
公司名称
联系地址
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!